Title:Nanoemulsion: A Novel Eon in Cancer Chemotherapy
VOLUME: 17 ISSUE: 18
Author(s):Prashant Sahu, Debashree Das, Vikash K. Mishra, Varsha Kashaw and Sushil Kumar Kashaw*
Affiliation:Department of Pharmaceutical Sciences, Dr. H.S. Gour Central University, Sagar, MP, Department of Pharmaceutical Sciences, Dr. H.S. Gour Central University, Sagar, MP, Department of Pharmaceutical Sciences, Dr. H.S. Gour Central University, Sagar, MP, Sagar Institute of Pharmaceutical Sciences, Sagar, MP, Department of Pharmaceutical Sciences, Dr. H.S Gour Central University, Sagar, MP
Keywords:Characterization, commercial brands cancer chemotherapy, drug delivery, nanoemulsion, patents, preparation.
Abstract:Cancer refers to an assemblage of lethal diseases characterized by abnormal growth of cells.
The most celebrated adverse effects accredited to the cytotoxic class of anticancer agents are constructed
owing to their inability to differentiate between the abnormally multiplying cancerous cell
mass and the rapidly dividing healthy cells of the human body. Consequently, unknown targets chemotherapy
for cancer play host to a multitude of adverse effects ranging from nausea, alopecia to torturous
ages associated with the current treatment etiquette. Nano-pharmaceuticals constitute the advanced
scale drug targeting technologies. Nanoemulsion is an important tool in the nano-technological arena
designed for clinical and therapeutic application. Currently among different nano-carriers, nanoemulsions
are extensively envisaged as efficient drug delivery systems for the targeted delivery of lipophilic
cytotoxic antineoplastic agents. Beauties of nanoemulsion include optical clarity, biocompatibility,
non-immunogenic, biodegradable, drug encapsulation, sustained and controlled release, nanometric
size, large surface area, ease of preparation and thermodynamic stability. After excessive delving, the
research fraternity has acknowledged nanoemulsions as proficient nanocarriers capable of effectively
addressing the low bioavailability and noncompliance issues associated with the conventional anticancerous
chemotherapeutic dosage forms. This review attempts to shed new light on the current status of
nanoemulsion in the cancer therapeutics, and commercial field on the basis of morphology, formulation,
characteristics and characterization parameters.
